Literature DB >> 22263272

[Development and characterization of a stable cell line expressing respiratory syncytial virus non-structural protein NS1].

Sheng Qin1, Yu-Tao Wang, Zi-Feng Yang, Qiao-Lian Chen, Wen-Da Guan, Shi-Guan Wu, Wen-Kuan Liu, Zhao-Guang Zhen, Hai-Tao Li, Rong Zhou.   

Abstract

To develop a stable cell line that could express the RSV NS1, the full-length RSV NS1 gene was generated by RT-PCR amplification from respiratory syncytial virus. NS1 gene was ligated with pBABE-puro to construct the recombinant retroviral expression plasmid pBABE-NS1, which was cotransfected into 293FT packaging cells with PIK packaging plasmid by calcium phosphate co-precipitation. The supernatant of 293FT was collected to infect HEp-2 cells, the resulting cell clones stably expressing NS1 were screened by puromycin. Using QPCR, CPE staining method and indirect immunofluorescence assay, the expression of NS1 at both gene and protein levels was identified. The recombinant plasmid pBABE-NS1 was identified by EcoRI and BamHI endonuclease digestion and the sequence analysis. QPCR results showed that the NS1 gene amplification in HEp-2-NS1 cells was 8483 fold higher than that in HEp-2 cells. Although the exogenous interferon was added, all cells were destroyed after 48 hours post infection using CPE staining method, showing that HEp-2-NS1 cells remained sensitive to the VSV virus. The results of RT-PCR and indirect immunofluorescence assay showed that the NS1 gene in HEp-2 cells could not only transcribe mRNA, but also express NS1 protein steadily. We had successfully established HEp-2-NS1 cell lines with stable expression of respiratory syncytial virus non-structural protein NS1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22263272

Source DB:  PubMed          Journal:  Bing Du Xue Bao        ISSN: 1000-8721


  1 in total

1.  Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line.

Authors:  Jinghang Jiang; Peipei Yang; Zhe Guo; Rirong Yang; Haojie Yang; Fuquan Yang; Lequn Li; Bangde Xiang
Journal:  World J Surg Oncol       Date:  2016-10-28       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.